Skip to main content
. 2016 Oct 11;8(3):5523–5539. doi: 10.18632/oncotarget.12566

Figure 4. Mechanism of targeting the interaction of EWS-FLI1 and PARP.

Figure 4

EWS-FLI1 interacts with PARP1, driving PARP1 expression. PARP1 promotes the transcriptional activation by EWS-FLI1. Treatment of ES with the PARP1 inhibitor olaparib could both disrupt the interaction between EWS-FLI1 and PARP1, and impair DNA repair, which represses tumorigenesis. PARP1, Poly(ADP-ribose) polymerase 1.